Literature DB >> 25061729

Association of miR-149C>T and miR-499A>G polymorphisms with the risk of hepatocellular carcinoma in the Chinese population.

X H Wang1, F R Wang1, Y F Tang2, H Z Zou3, Y Q Zhao3.   

Abstract

We investigate the potential association of miR-149C>T and miR-499A>G polymorphisms and the risk of hepatocellular carcinoma (HCC). A matched case-control study of 152 cases and 304 controls were conducted. The miR-149C>T and miR-499A>G genotypes were analyzed using duplex polymerase chain reaction with restricted fragment length polymorphism. HCC patients were more likely to be smokers and drinkers, have hepatitis B and C virus infections, and a family history of cancer. The miR-149 CC genotype was associated with a reduced risk of HCC, while the miR-499 GG genotype was associated with an increased risk of HCC. However, we did not find that the miR-149 CC and miR-499 GG genotypes were associated with risk of HCC, and no interaction was found between miR-149C>T and miR-499A>G polymorphisms and hepatitis B virus infection. In conclusion, the miRNA-149C>T and miR-499A>G polymorphisms were found to play an important role for HCC risk in China. This finding could be useful in identifying people at high risk for the disease for early intervention.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25061729     DOI: 10.4238/2014.July.4.20

Source DB:  PubMed          Journal:  Genet Mol Res        ISSN: 1676-5680


  16 in total

Review 1.  Noncoding RNA as therapeutic targets for hepatocellular carcinoma.

Authors:  Joseph George; Tushar Patel
Journal:  Semin Liver Dis       Date:  2015-01-29       Impact factor: 6.115

2.  Association of four common SNPs in microRNA polymorphisms with the risk of hepatocellular carcinoma.

Authors:  Xinhong Li; Kai Li; Zhongjun Wu
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

3.  The miR-149 rs2292832 T/C polymorphism may decrease digestive cancer susceptibility: an updated meta-analysis.

Authors:  Lin Li; Tao Liu; Zuo Li; Lixin Zhang; Zhiqiang Zhang
Journal:  Int J Clin Exp Med       Date:  2015-09-15

4.  Pre-miR-149 rs71428439 polymorphism is associated with increased cancer risk and AKT1/cyclinD1 signaling in hepatocellular carcinoma.

Authors:  Jiantao Wu; Shemin Lv; Jianbo An; Chunhui Lu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

Review 5.  The association of common functional polymorphisms in mir-146a and mir-196a2 and hepatocellular carcinoma risk: evidence from a meta-analysis.

Authors:  Qiliu Peng; Shan Li; Xianjun Lao; Zhiping Chen; Ruolin Li; Yan Deng; Xue Qin
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

6.  Association of miR-196a2 rs11614913 and miR-499 rs3746444 polymorphisms with cancer risk: a meta-analysis.

Authors:  Wanjun Yan; Xiaoyan Gao; Shuqun Zhang
Journal:  Oncotarget       Date:  2017-11-20

7.  MiR-146a and miR-196a-2 polymorphisms are associated with hepatitis virus-related hepatocellular cancer risk: a meta-analysis.

Authors:  Tian Tian; Meng Wang; Wenge Zhu; Zhi-Ming Dai; Shuai Lin; Peng-Tao Yang; Xing-Han Liu; Kang Liu; Yu-Yao Zhu; Yi Zheng; Meng Liu; Zhi-Jun Dai
Journal:  Aging (Albany NY)       Date:  2017-01-31       Impact factor: 5.682

8.  A Meta-Analysis of miR-499 rs3746444 Polymorphism for Cancer Risk of Different Systems: Evidence From 65 Case-Control Studies.

Authors:  Xianglin Yang; Xuelian Li; Baosen Zhou
Journal:  Front Physiol       Date:  2018-06-12       Impact factor: 4.566

9.  Association of the miR-196a2 C>T and miR-499 A>G polymorphisms with hepatitis B virus-related hepatocellular carcinoma risk: an updated meta-analysis.

Authors:  Shao-Liang Zhu; Jian-Hong Zhong; Wen-Feng Gong; Hang Li; Le-Qun Li
Journal:  Onco Targets Ther       Date:  2016-04-15       Impact factor: 4.147

Review 10.  miR-149 in Human Cancer: A Systemic Review.

Authors:  Yunjie He; Dandan Yu; Lingping Zhu; Shanliang Zhong; Jianhua Zhao; Jinhai Tang
Journal:  J Cancer       Date:  2018-01-01       Impact factor: 4.207

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.